A federal judge temporarily halted three parts of the Trump administration's vaccine-policy changes on March 16, 2026. The order is substantial, but it is narrower than a final judgment overturning the administration's entire vaccine agenda.
In the first of those actions, US District Judge Brian E. Murphy paused a CDC memo that had revised the childhood immunization schedule in January. He also stayed the appointments of 13 challenged members of the Advisory Committee on Immunization Practices, or ACIP, and all votes taken by those appointees. The court granted preliminary relief only in part while the lawsuit continues.
The Order Names Three Actions
The 45-page order in American Academy of Pediatrics v. Kennedy lists its relief precisely. First, it stays the January memo under Section 705 of the Administrative Procedure Act. Second, it stays the appointments made on June 11 and September 11, 2025, and January 13, 2026. Third, it stays votes taken by the now-stayed committee members.
That distinction corrects two easy overstatements. The court did not issue a final ruling that every Kennedy vaccine policy was unlawful, and it did not permanently remove the federal government's authority to make immunization recommendations. Murphy expressly declined additional relief requested by the plaintiffs at this stage.
The ruling also did not prohibit HHS from ever assembling a new ACIP. The judge reasoned that choosing the committee's balance belongs first to the agency, while deciding whether the agency met federal requirements belongs to the court. Staying the challenged appointments was therefore less intrusive than ordering the government to select particular members or barring any future committee meeting.
Why the Court Found the Process Likely Unlawful
The plaintiffs are medical and public-health organizations that challenged several federal actions. For preliminary relief, they had to show more than disagreement with the administration's policy. The court examined whether the agencies followed the procedures and legal constraints that govern federal decision-making.
On the January schedule memo, Murphy concluded that the plaintiffs were likely to show the CDC acted contrary to law and arbitrarily and capriciously. The order says the CDC departed from its longstanding practice of revising immunization schedules after ACIP recommendations and gave no sufficient explanation for bypassing that process. A presidential directive, the court said, does not exempt a final agency action from review under the APA.
The committee appointments raised a separate issue under the Federal Advisory Committee Act. Federal law requires advisory committees to be fairly balanced in relation to their work. The court did not apply a numerical quota or declare that one identifiable viewpoint must receive a seat. It focused on the unexplained departure from the agency's membership-balance plan, the vetting process and the overall composition of the reconstituted committee.
On the record before it, the court found the plaintiffs likely to show that the 13-member panel failed that fair-balance requirement. Because the appointment process appeared to affect the full challenged committee, Murphy stayed all 13 appointments rather than trying to remove selected individuals himself.
Preliminary Relief Is Not a Final Merits Decision
A preliminary order preserves a position while litigation proceeds; it does not settle every factual and legal dispute. The opinion repeatedly uses the likelihood-of-success standard. The government can continue contesting the plaintiffs' claims, build the administrative record and seek appellate review.
HHS said it expected the decision to be overturned. The administration filed a notice of appeal on April 29, and Georgetown Law's litigation tracker lists the appeal as pending and the district-court case as stayed pending that appeal. That procedural stay of district-court litigation should not be confused with a final appellate ruling on whether Murphy's order was correct.
The immediate operational effect was still real. ABC News reported that the ACIP meeting scheduled for March 18 and 19 was postponed after the appointments were stayed. But the old claim that the United States was left without any lawful way to issue influenza or RSV recommendations goes beyond the order. The opinion addresses the identified memo, appointments and votes; it does not announce a permanent shutdown of federal vaccine governance.
The Hard Question Is Whether the Record Can Survive Review
Vaccine recommendations influence clinical practice, insurance coverage and public trust. That makes the underlying scientific evidence important, but the March order is primarily a ruling about lawful process. A court reviewing agency action asks whether officials used the authority Congress gave them, followed required procedures and explained a departure from established practice.
The administration remains free to argue for different vaccine policy. What it cannot safely assume is that naming a policy goal supplies the missing administrative record. If HHS wants its changes to survive hostile review, it must show how the evidence was assessed, how conflicts and expertise were vetted, why the advisory body is fairly balanced and why a longstanding process was changed.
The same standard protects policy change rather than preventing it. A reasoned record allows a new administration to revise old guidance without asking courts or the public to trust political preference alone. A thin record does the opposite: it converts every scientific dispute into a test of personal authority. The March ruling's sharpest message is therefore procedural. In a system where recommendations carry national consequences, power to change policy is not permission to skip the proof.